#62025CC0121Advocate General opinion on EU hazard classification of silanamine
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Assesses whether EU chemical regulators properly classified silanamine, a surface-treated synthetic amorphous silica, as a substance that may damage lungs after repeated inhalation exposure. The opinion focuses on Evonik’s challenge to an EU regulation that added this EU-wide hazard classification under the CLP chemicals regime.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- No immediate compliance change: this is an Advocate General opinion in a pending EU Court of Justice appeal, not the final judgment.
- The opinion examines how regulators may use read-across and weight-of-evidence methods when classifying chemical hazards.
- It also reviews procedural challenges, including the 18-month deadline for the ECHA risk committee opinion and whether the public consultation was sufficient.
Obligations
What this law requires
EU law provision discussed: Article 4(1) of Regulation (EC) No 1272/2008 requires manufacturers, importers and downstream users to classify substances or mixtures under Title II before placing them on the EU market.
EU law provision discussed: Article 4(3) of Regulation (EC) No 1272/2008 provides that where a substance has a harmonised classification and labelling entry in Part 3 of Annex VI, it must be classified according to that entry for the hazard classes or differentiations covered by the entry; Title II self-classification is still required for hazard classes not covered by the harmonised entry.
EU law provision discussed: Article 9(1) and (3) of Regulation (EC) No 1272/2008 requires manufacturers, importers and downstream users to evaluate identified hazard information against Annex I classification criteria; where criteria cannot be applied directly, they must use a weight-of-evidence determination with expert judgment.
EU law provision discussed: Article 37(4) of Regulation (EC) No 1272/2008 requires ECHA’s Committee for Risk Assessment to adopt an opinion on a harmonised classification and labelling proposal within 18 months of receipt and to give parties concerned an opportunity to comment.
EU law provision discussed: Article 37(5) of Regulation (EC) No 1272/2008 provides that the Commission must adopt delegated acts without undue delay to amend Annex VI where it finds harmonisation of the substance’s classification and labelling appropriate.